Malignant Melanoma Archive - Seite 7 von 19 - IOZK

Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells

2015-04-02

Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model

2014-11-24

Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response

2014-09-23

Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route

2014-08-14

Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised „proof-of-principle“ phase II study

2014-07-22

Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients

2014-07-17

Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells

2014-07-01

Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma

2014-02-27

Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates

2014-02-05

Novel dendritic cell-based vaccination in late stage melanoma

2014-01-01